Van Lanschot Kempen Investment Management’s Medpace MEDP Stock Holding History

Van Lanschot Kempen Investment Management’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.32M	Buy	+17,593	New	+$8.12M	0.07%	162

Other funds holding MEDP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Van Lanschot Kempen Investment Management's MEDP Position: Q2 2026 in Review

Van Lanschot Kempen Investment Management opened a new position in Medpace (MEDP) in Q2 2026: 17,593 shares worth $9.32M. The stake represents 0.07% of the portfolio and ranks #162 among its holdings.

693 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

Van Lanschot Kempen Investment Management held 17,593 shares of Medpace worth $9.32M as of Q2 2026.
Medpace was a new Van Lanschot Kempen Investment Management position in Q2 2026.
Medpace made up 0.07% of Van Lanschot Kempen Investment Management's portfolio in Q2 2026, its #162 holding.
693 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Van Lanschot Kempen Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.